|Day's range||63.05 - 63.46|
|52-week range||46.86 - 63.85|
|PE ratio (TTM)||36.80|
|Earnings date||8 Aug 2017|
|Dividend & yield||0.42 (0.66%)|
|1y target est||66.19|
The future of the U.S. health-care system has engendered fierce debate on both sides of the political aisle. For example, which drugmakers and medical-device companies are developing breakthrough therapies? Which companies are developing and using technology to improve how health care is delivered?
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Zoetis, Inc. Here are 5 ETFs with the largest exposure to ZTS-US. Comparing the performance and risk of Zoetis, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Zoetis (ZTS) stock has risen ~17.3% in 2Q17, while it has risen ~15.4% year-to-date as of July 7, 2017.